News
Jesduvroq Approved for Anemia of CKD in Patients on Dialysis
Daprodustat is an oral hypoxia-inducible factor prolyl hydroxylase inhibitor.
Participants with total seafood n-3 PUFA level in highest vs lowest fifth had 13% lower risk for incident chronic kidney disease.
Layered approach involves initially combining lifestyle interventions, self-management, and first-line pharmacotherapy.
Decrease in alcohol consumption, easier diabetes control perception were factors associated with better glycemic control